Aspirin; Omeprazole Patent Expiration
Aspirin; Omeprazole is Used for secondary prevention of cardiovascular and cerebrovascular events in patients at risk of developing aspirin-associated gastric ulcers, as well as for the treatment of cardiovascular disease, cardiovascular events, cerebrovascular events, and risk-reduction of aspirin-associated gastric ulcers. It was first introduced by Genus Life Sciences Inc
Aspirin; Omeprazole Patents
Given below is the list of patents protecting Aspirin; Omeprazole, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Yosprala | US9539214 | Compositions and methods for delivery of omeprazole plus acetylsalicylic acid | Mar 13, 2033 | Genus Lifesciences |
| Yosprala | US9987231 | Compositions and methods for delivery of omeprazole plus acetylsalicylic acid | Jan 02, 2033 | Genus Lifesciences |
| Yosprala | US6926907 | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
Feb 28, 2023
(Expired) | Genus Lifesciences |
| Yosprala | US8206741 | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
Feb 28, 2023
(Expired) | Genus Lifesciences |
| Yosprala | US9364439 | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
May 31, 2022
(Expired) | Genus Lifesciences |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Aspirin; Omeprazole's patents.
Latest Legal Activities on Aspirin; Omeprazole's Patents
Given below is the list recent legal activities going on the following patents of Aspirin; Omeprazole.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Maintenance Fee Reminder Mailed Critical | 12 Feb, 2024 | US8206741 |
| Expire Patent Critical | 11 Jul, 2022 | US9987231 |
| Maintenance Fee Reminder Mailed Critical | 24 Jan, 2022 | US9987231 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 10 Sep, 2020 | US9539214 |
| Surcharge for Late Payment, Large Entity | 10 Sep, 2020 | US9539214 |
| Maintenance Fee Reminder Mailed Critical | 31 Aug, 2020 | US9539214 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 26 Dec, 2019 | US8206741 |
| Email Notification Critical | 18 Mar, 2019 | US8206741 |
| Change in Power of Attorney (May Include Associate POA) Critical | 18 Mar, 2019 | US8206741 |
| Email Notification Critical | 14 Mar, 2019 | US6926907(Litigated) |
Aspirin; Omeprazole's Family Patents
